Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial.
Int J Mol Sci. 2023 Sep 20;24(18):14315. doi: 10.3390/ijms241814315.
Int J Mol Sci. 2023.
PMID: 37762625
Free PMC article.
Clinical Trial.
No effect of topical digoxin and furosemide for patients with actinic keratosis.
Huisman BW, Nené LEH, Linders FLL, Gambrah TK, van der Kolk TN, de Kam ML, Bavinck JNB, Burggraaf J, Feiss G, Rissmann R.
Huisman BW, et al. Among authors: gambrah tk.
J Eur Acad Dermatol Venereol. 2023 Feb;37(2):e172-e174. doi: 10.1111/jdv.18624. Epub 2022 Oct 8.
J Eur Acad Dermatol Venereol. 2023.
PMID: 36177541
No abstract available.
Item in Clipboard
Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide composition.
Rousel J, Nădăban A, Saghari M, Pagan L, Zhuparris A, Theelen B, Gambrah T, van der Wall HEC, Vreeken RJ, Feiss GL, Niemeyer-van der Kolk T, Burggraaf J, van Doorn MBA, Bouwstra JA, Rissmann R.
Rousel J, et al. Among authors: gambrah t.
Exp Dermatol. 2024 Jan;33(1):e14952. doi: 10.1111/exd.14952. Epub 2023 Nov 16.
Exp Dermatol. 2024.
PMID: 37974545
Item in Clipboard
Cite
Cite